Trial Profile
Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2013
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Adefovir dipivoxil
- Indications Hepatitis B
- Focus Biomarker; Therapeutic Use
- Acronyms DNA-EVAL
- 02 Feb 2010 New trial record